Wegovy regrets — when treatment feels harder than expected

You're two months in and it's nothing like what you imagined

This is, genuinely, the most common version of Wegovy regret. You read that people lost around 15% of their body weight over 68 weeks in the STEP 1 trial, and that figure is real, drawn from robust clinical evidence published in the New England Journal of Medicine. But a trial average covers a wide range of individual results, and 68 weeks is a long time. At week eight, on 0.5mg or 1mg, you may be nowhere near the maintenance dose that produced those results. That's not failure; that's the titration schedule doing its job of protecting your gut while your body adjusts.

The question worth asking is whether your expectations were calibrated to the full timeline. Most people reach the 2.4mg maintenance dose around week 16 to 20 at the earliest, and meaningful weight loss often accelerates after that point. If you started in January and you're checking the scales in February, the picture is genuinely incomplete. The Wegovy dosing schedule page explains the step-up process in plain terms, which can help reframe where you actually are in the journey.

That said, if you've been on a stable dose for several months and progress has stalled entirely, that is worth raising with your prescriber, not ignoring. Dose review is part of what clinical oversight exists for.

The side effects are making daily life difficult

Nausea, fatigue, loose stools, reflux: the gastrointestinal profile of semaglutide is well documented by the NHS medicines guidance on semaglutide, and it can be unpleasant, especially in the first few weeks after a dose increase. For some people it passes quickly. For others it lingers and starts to affect work, meals and mood in ways that feel disproportionate to the benefit.

The practical steps that tend to help (smaller portions at each meal, eating slowly, cutting alcohol and high-fat food around injection days) are worth trying systematically before concluding the medicine doesn't suit you. Timing matters too. Some people find injecting on a Friday evening means the worst of any nausea lands over a weekend rather than a Monday morning before the school run. It's also worth knowing that storage plays a role in how well the medicine performs, so if you've had any doubts about your pen, our page on what to do if your Wegovy gets warm is worth a read before your next injection.

If side effects are genuinely severe or persistent, your prescriber can consider a slower titration, staying longer at a lower dose, or assessing whether something else is going on. The one side effect that should always prompt urgent medical attention is severe, persistent stomach pain that radiates to the back, this is a potential sign of pancreatitis, and the MHRA highlighted it specifically in their January 2026 Drug Safety Update on GLP-1 medicines. Don't wait to be seen if you have that symptom.

Cravings shifting unexpectedly? Some people find their relationship with food changes in ways they didn't anticipate, and if you've noticed yourself reaching for sugar more than usual, our page on craving sweets on Wegovy addresses one of the more puzzling experiences people report, with further detail on how Wegovy interacts with sweet foods specifically for anyone who wants to dig deeper into that question.

You're wondering whether you chose the right treatment

This is a legitimate thing to wonder, and a prescriber should be able to have that conversation with you openly. Semaglutide is a GLP-1 receptor agonist, it works through one pathway. Tirzepatide, sold in the UK as Mounjaro, acts on both GLP-1 and GIP receptors, and in the SURMOUNT-5 trial produced greater average weight reduction than semaglutide 2.4mg over 72 weeks. If semaglutide isn't delivering the results you hoped for, a clinical conversation about whether a different medicine might suit you better is reasonable. That's not the same as chasing the highest possible dose regardless of tolerance; it's a clinical assessment of what's actually working.

For a broader look at what's available and how the medicines compare, our full Wegovy guide and the weight-loss treatment options page both give context. The decision about whether to switch, stay the course or adjust your approach is exactly the kind of thing a prescriber should be involved in, not something to resolve alone based on forum posts.

You're thinking about stopping, here's what that decision involves

Stopping semaglutide without a plan is, clinically, the option most likely to produce regret down the line. The medicine works while you're taking it; the evidence is clear that appetite and hunger tend to return when treatment stops, and weight regain is common. That's not a moral failure, it reflects how the medicine interacts with appetite-regulating hormones, and it's why NHS England's guidance on weight-management injections emphasises ongoing clinical review as part of treatment.

If you want to stop (because of side effects, cost, a medical reason, or simply because you've made that decision) talk to your prescriber about how to do it thoughtfully. A slower wind-down, dietary planning, and a clear picture of what happens next makes the transition far more manageable than a sudden stop. If you're still finding your footing with treatment and want a clinical team you can actually reach, our team at nume offers aftercare seven days a week for exactly these conversations. You can also read about what legitimate Wegovy access looks like if you're weighing your options. When you're ready to discuss your situation with a prescriber, you can check your eligibility for a free consultation.